Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05022485
Other study ID # CMG2020-32T
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 11, 2022
Est. completion date July 2027

Study information

Verified date July 2023
Source Zimmer Biomet
Contact Paolo Rusconi
Phone +41 798856425
Email paolo.rusconi@zimmerbiomet.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Primary objective of this study is to compare fracture related infection (FRI) rates of ZNN Bactiguard Tibia to conventional uncoated titanium-alloy nails 12 months after tibia fracture fixation. The secondary objectives are confirmation of safety, performance and clinical benefits of ZNN Bactiguard implant and related instrumentation12 months after fracture fixation.


Description:

This is a multicenter, prospective, Post-market Clinical Follow-up (PMCF) Study with retrospective controls. The study will enroll patients that will be implanted with the Zimmer Natural Nail Bactiguard Tibia device and retrospective controls implanted with standard titanium-alloy tibia nails. 500 tibias will be recruited at maximum 15 sites and allocated on a 1:1 ratio into an: - investigational group (prospective/consecutive series of 250 tibias treated with ZNN Bactiguard tibia) - a control group (retrospective series of 250 tibias treated with uncoated titanium-alloy tibia nail - data collection will be retrospective, these subjects will not have to undergo any study-related procedure). The primary endpoint is the Fracture Related Infection (FRI) rate in the study population 12 months after fracture fixation. The secondary endpoint is the confirmation of safety, performance and clinical benefits of ZNN Bactiguard implant and related instrumentation through the following measure systems: - Radiologic (RUST) & clinical (FIX-IT) fracture healing 12 months after fracture fixation (performance). - Patients' outcomes assessed by the Oxford Knee Score 12 months after fracture fixation (clinical benefits). - EQ5D-5L (patients' quality of life). - Incidence and frequency of adverse events (safety). Data will be collected at 2 weeks, 3 months, 6 months and 1 year after fracture fixation.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date July 2027
Est. primary completion date July 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient must be 18 or older. - Patient has signed IRB/EC-approved informed consent (if applicable for retrospective controls, based on local requirements). - Patient suffered primary tibia fracture (monolateral or bilateral) at high risk of infection, eligible for fixation by intramedullary (IM) nailing (standard or suprapatellar approach) and meets at least one of the following conditions: - Open fractures (incl. gunshot fractures): Gustilo Type I, II, III A and III B. - Delayed treatment (initial treatment by external fixation due to swelling/ high energy trauma followed by definitive treatment by intramedullary nail). - Fracture associated with ipsilateral leg compartment syndrome treated with fasciotomy wound(s). - Closed fractures with severe tissue damage: Tscherne grade C2 and C3. - Patient: - will be treated with ZNN Bactiguard tibia for inclusion in investigational group (retrospective enrollment is allowed up to 1st follow-up visit); - was treated with uncoated (conventional) titanium-alloy intramedullary tibia nail for inclusion in control group; Exclusion Criteria: - Patient is unwilling or unable to give consent. - Patient is not expected to survive follow-up schedule. - Patient is anticipated to be non-compliant to the study protocol. - Patient has a mental or neurological condition or alcohol/drug addiction that will not allow for proper informed consent and/or participation in follow-up program. - Patient is a prisoner. - Patient is known to be pregnant and/or breastfeeding. - Patient suffered tibia fracture that meets any of the following conditions: - Pathologic fracture. - Gustilo Type IIIC open fracture. - Patient has multisegmented fracture NOT eligible for fixation by intramedullary nailing. - Patients with wound closure more than 10 days after injury. - Besides IM nail, patient requires additional tibia fixation by plate (additional tibia fixation by screw(s) and/or fibula plate fixation are allowed). - Concomitant with fracture, patient suffered head injury with Abbreviated Injury Score (AIS) = 3. - For control group: - patient doesn't have all the minimum required data available: 1. demographic information 2. injury classification 3. FRI information 4. operative report and device information 5. radiographic analyses (until fracture healing or confirmation of non-union leading to reoperation) - Tibia medullary canal is obliterated by a previous fracture or tumor* - Tibia bone shaft having excessive bow or a deformity* - Lack of bone substance or bone quality, which makes stable seating of the nail implant impossible* - All concomitant diseases that can impair the operation, functioning or the success of the nail implant* - Insufficient blood circulation* - Skeletally immature patients* - Infection* - ZNN Bactiguard tibia contraindication

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ZNN Bactiguard tibia
Tibia fracture fixation

Locations

Country Name City State
Austria Tirolkliniken Innsbruck Innsbruck
France Hôpital Ambroise-Paré Boulogne-Billancourt
France Hôpitaux Universitaires de Marseille Nord Marseille
Germany Universitätsklinikum Leipzig Leipzig
Germany Universitätsklinikum Marburg Marburg Hesse
Germany Universitätsklinikum Regensburg Regensburg
Italy AOU Policlinico di Bari Bari
Italy Azienda Ospedaliero-Universitaria Careggi Firenze
South Africa Groote Schuur Hospital Cape Town
South Africa Khayelitsha Hospital Cape Town
South Africa Tygerberg Hospital Cape Town
South Africa Chris Hani Baragwanath Hospital Johannesburg
Spain Hospital Universitario Valle de Hebrón Barcelona Catalunya
Switzerland Kantonsspital Winterthur Winterthur Zurich
United Kingdom Royal Infirmary of Edinburgh Edinburgh
United Kingdom Leeds General Infirmary Leeds
United Kingdom King's College Hospital NHS Trust London
United Kingdom The Royal London Hospital London

Sponsors (1)

Lead Sponsor Collaborator
Zimmer Biomet

Countries where clinical trial is conducted

Austria,  France,  Germany,  Italy,  South Africa,  Spain,  Switzerland,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fracture related infection (FRI) rate in investigational and control group FRI diagnosed according to the updated diagnostic algorithm drafted by the Fracture-Related Infection Consensus Group (Definition and diagnosis of fracture-related infection, M McNally,G Govaert, M Dudareva, M Morgenstern, W J Metsemakers, EFORT Open Rev 2020;5:614-619.) 12 months after fracture fixation
Secondary Tibia fracture healing assessed radiologically through Radiographic Union Scale in Tibial fractures (RUST) score The RUST score assigns each tibial cortex (anterior, posterior, medial and lateral) a score from 1 to 3, based on the appearance on the X-ray. The scores of all cortices combined will give a minimum score of 4 (definitely not healed) up to a maximum of 12 (completely healed). 12 months after fracture fixation
Secondary Tibia fracture healing assessed clinically through the Function IndeX for Trauma (FIX-IT) score The FIX-IT score assesses the subject's pain and ability to bear weight on lower extremity fractures. It ranges from 0 to 12 points, with 12 points representing the highest level of limb function. 12 months after fracture fixation
Secondary Limb functionality measured through the Oxford Knee Score The Oxford Knee Score consists of twelve questions regarding knee functionality and pain. The score ranges from 12 to 60 points, with 12 points indicating the best outcome. 12 months after fracture fixation
Secondary Quality of life of study participants assessed through the EQ-5D-5L questionnaire The EQ-5D is a self-reported descriptive questionnaire about the patient's quality of life composed of 5 questions referring to mobility, self-care, daily activities, pain and anxiety/depression. Each question has 3 possible answers, which define the level of perceived problems (none, moderate,extreme problem) 12 months after fracture fixation
Secondary Incidence and frequency of adverse events Frequency and incidence of recorded AEs will be calculated 12 months after fracture fixation
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05459038 - Clinical Validation of the C-Arm Rotational View (CARV) to Avoid Rotational Malalignment After Intramedullary Nailing of Tibial Shaft Fractures. N/A
Terminated NCT02845245 - Comminuted Intra-Articular Distal Tibia Fracture Fixation Using Computer Techniques N/A
Completed NCT02456194 - Management of Traumatic Bone Defects in Tibial Plateau Fractures With Antibiotic-Impregnated Biodegradable Calcium Sulfate Beads: A Prospective Clinical Trial N/A
Terminated NCT00667849 - Trial to Evaluate UltraSound in the Treatment of Tibial Fractures N/A
Completed NCT01132508 - Use of a Reinforced Injectable Calcium Phosphate Bone Cement in the Treatment of Tibial Plateau Fractures N/A
Completed NCT00512434 - Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture N/A
Completed NCT00161616 - Study Evaluating InductOs in Diaphyseal Tibia Fractures Phase 4
Terminated NCT03881241 - Safety Study of Treatment of Leg Fractures
Completed NCT02750072 - INfrapatellar Versus SUprapatellar Reamed Intramedullary Nailing for Fractures of the Tibia N/A
Completed NCT04015167 - A Post-Market Clinical Evaluation of the Treatment of Tibia Fractures With the T2 Alpha Tibia Nailing System
Recruiting NCT06451510 - Knee Osteoarthritis in the Region of Norrbotten
Completed NCT05613257 - Distal Targeter vs Free-hand N/A
Completed NCT03388879 - Reamed Nailing Versus Taylor Spatial Frame in Tibia Shaft Fractures N/A
Completed NCT02491047 - Safety and Performance of BonyPid-1000™ in the Treatment of Gustilo I, II, IIIA and IIIB Tibial Open Fractures N/A
Completed NCT01797640 - Intramedullary Nailing of Tibia Fractures N/A
Recruiting NCT03232216 - Vitamin D Supplementation and Tibia Fracture. Does it Improve Healing Rate? N/A
Withdrawn NCT03826784 - Bone Healing Accelerant Versus Standard of Care for Open Tibia Fractures Phase 3
Terminated NCT00253981 - Light Therapy in the Treatment of Leg Pain N/A
Completed NCT05303389 - Posterior Plating Versus Anterior to Posterior Screws in Fixation of Posterior Column in Pilon Fractures N/A
Recruiting NCT05272631 - Depuy Synthes Lower Extremity Shaft Nail Registry